|
ATEC
|
Alphatec Holdings, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
AMEH
|
Apollo Medical Holdings, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
OMI
|
Owens & Minor, Inc.
|
0.02%
|
US
|
NYSE
|
|
NEO
|
NeoGenomics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
MD
|
Mednax, Inc.
|
0.02%
|
US
|
NYSE
|
|
MXCT
|
Maxcyte Inc
|
0.01%
|
UK
|
LSE
|
|
VREX
|
Varex Imaging Corporation
|
0.01%
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
VRAY
|
ViewRay, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.01%
|
US
|
NASDAQ
|
|
UFPT
|
UFP Technologies, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
TMCI
|
Treace Medical Concepts, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
SRRK
|
Scholar Rock Holding Corporation
|
0.01%
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|